ACHE and Alzheimer disease: Although there are recommended therapies for AD, such as acetylcholinesterase inhibitors and the N-methyl-D-aspartate receptor antagonists, they are inefficient and do not prevent disease progression, reflecting our incomplete understanding of AD pathogenesis.